STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
bBHC introduced Cell 97.7 and Celgen branded products at International Beauty Expo 2019
TV Chosun ‘2019 Management Awards Ceremony’
“Development of nEPS, Efforts to overcome incurable diseases.”
STRI registered a patent for cartilage cell differentiation using nEPS(newly elicited pluripotent stem cell without side effects by natural compound) in the United States
STRI achieved positive results in their research about alleviating trigeminal neuralgia using stem cell treatment with an affiliated hospital
STRI achieved positive results in their treatment of trigeminal neuralgia using stem cells
Development of nEPS (newly Elicited Pluripotent Stem Cells without side effects using natural compounds), Leading to the ability to overcome incurable diseases!
